Canagliflozin 842133-18-0

98% up by HPLC

Product categories

New Products

Product Details

Product Information

Product name	Canagliflozin
CAS No.	842133-18-0
Molecular Formula	C24H25FO5S
Molecular Weight	444.524
Quality Standard	99% up by HPLC
Appearance	White to off-white powder

COA of Canagliflozin

ITEMS	SPECIFICATION	RESULT
Appearance	White to off-white powder	Conforms
Related substance	Purity(HPLC) ≥ 99.0%	99.8%
	Single impurity ≤ 0.5%	0.08% max
	Total impurity ≤ 1.0%	0.2%
Water	≤ 3.0%	1.5%
Conclusion	The sample meets the standard requirements

Usage

Canagliflozin is an SGLT2 inhibitor drug that lowers blood sugar by breaking down glucose and expelling it through the kidneys. In addition to the good blood sugar control effect, Canagliflozin is most notable for its weight loss effect and few hypoglycemic events, which has broad prospects. On June 9, 2012, according to the results of two phase III clinical trials, Johnson & Johnson's (JNJ) experimental type 2 diabetes drug canagliflozin is superior to Merck's Januvia and another old drug glimepiride in reducing blood sugar. At the same time, canagliflozin has a more significant weight loss effect; and compared with glimepiride, canagliflozin triggers far fewer hypoglycemic events.

*Products under the patent are only for R&D use